Replies to post #218861 on Biotech Values

[DewDiligence]

RVNC—

1) News of an ex-US partnership for RT002 could come at any time; it does not necessarily have to wait until RVNC submits the MAA for glabellar lines.

2) Yes.

3) On average, FDA reviews of supplemental BLAs are about two months shorter than (original) BLAs.